Page last updated: 2024-11-04

sulfamethoxypyridazine and Hemolysis

sulfamethoxypyridazine has been researched along with Hemolysis in 2 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thornhill, M1
Pemberton, M1
Buchanan, J1
Theaker, E1
Stavem, P1
Strömme, J1
Lorkin, PA1
Lehmann, H1

Trials

1 trial available for sulfamethoxypyridazine and Hemolysis

ArticleYear
An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid.
    The British journal of dermatology, 2000, Volume: 143, Issue:1

    Topics: Aged; Anti-Infective Agents; Drug Hypersensitivity; Female; Hemolysis; Humans; Male; Middle Aged; Mo

2000

Other Studies

1 other study available for sulfamethoxypyridazine and Hemolysis

ArticleYear
Haemoglobin M Saskatoon with slight constant haemolysis, markedly increased by sulphonamides.
    Scandinavian journal of haematology, 1972, Volume: 9, Issue:6

    Topics: Adult; Blood Protein Electrophoresis; Chromatography, Ion Exchange; Cyanides; Cyanosis; Hemoglobins,

1972